Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [<sup>18</sup>F] Fluorothymidine Positron Emission Tomography: A Pilot Study
Wei Chen(Army Medical University), Timothy F. Cloughesy(University of California, Los Angeles), James Sayre(University of California, Los Angeles), Daniel Silverman(University of California, Los Angeles), Albert Lai(AbbVie (United States)), Nagichettiar Satyamurthy, Michael E. Phelps(National Academy of Engineering), Cheri Geist(University of California, Los Angeles), Whitney B. Pope(University of California, Los Angeles), Johannes Czernin(University of California, Los Angeles), Sibylle Delaloye(University of California, Los Angeles)
Cited by 391
Related Papers
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Quantitation in Positron Emission Computed Tomography
|Journal of Computer Assisted Tomography|1979|1.2k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Positron Emission Tomography in Evaluation of Dementia
|JAMA|2001|952